Pompilio, G.; Morabito, A.; Cortinovis, D. L.; Integlia, D. Budget Impact Analysis of Afatinib for First-Line Treatment of Non-Small Cell Lung Cancer (NSCLC) Patients With Uncommon EGFR Mutations. Grhta 2022, 9, 22-29.